Development of epigenetic diagnostic kit for predicting risk of development of symptomatic Alzheimers disease

摘要

The present invention relates to a composition, kit and method for diagnosing Alzheimer's disease mild cognitive impairment or predicting the risk of progression to Alzheimer's disease dementia by detecting the methylation level of a gene CpG region.